Review
Nature Reviews Drug Discovery 3, 301-317 (April 2004) | doi:10.1038/nrd1343
Small-molecule inhibitors of protein–protein interactions: progressing towards the dream
Michelle R. Arkin1 & James A. Wells1 About the authors
Abstract
Protein–protein interactions have a key role in most biological processes, and offer attractive opportunities for therapeutic intervention. Developing small molecules that modulate protein–protein interactions is difficult, owing to issues such as the lack of well-defined binding pockets. Nevertheless, there has been important progress in this endeavour in recent years. Here, we use illustrative examples to discuss general strategies for addressing the challenges inherent in the discovery and characterization of small-molecule inhibitors of protein–protein interactions.
- View At a Glance
Author affiliations
-
Sunesis Pharmaceuticals, 341 Oyster Point Boulevard, South San Francisco, California 94080, USA.
Email: mra@sunesis.com
Email: jaw@sunesis.com
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Ending the prolonged life of cancer cellsNature Chemical Biology News and Views (01 Jun 2005)
A new school for screeningNature Biotechnology News and Views (01 Feb 2005)
See all 5 matches for News And ViewsRESEARCH
Inhibition of a viral enzyme by a small-molecule dimer disruptorNature Chemical Biology Article (01 Sep 2009)
See all 11 matches for Research
